RedHill Biopharma (RDHL) Change in Accured Expenses (2012 - 2022)
RedHill Biopharma (RDHL) posted quarterly Change in Accured Expenses of -$3.2 million for Q4 2022, down 1151.78% year-over-year from $309000.0 in Q4 2021, and down 429.28% quarter-over-quarter from $987000.0 in Q3 2022.
RedHill Biopharma (RDHL) Change in Accured Expenses (2012 - 2022) Analysis & Trends
RedHill Biopharma (RDHL) has reported Change in Accured Expenses for 11 consecutive years, with -$3.2 million the latest figure, recorded in Q4 2022.
- In Q4 2022, Change in Accured Expenses fell 1151.78% year-over-year to -$3.2 million; the TTM figure through Dec 2022 stood at -$1.2 million (up 62.15% YoY), while the FY2025 annual figure was $2.5 million, down 18.51% from the prior year.
- Change in Accured Expenses retreated to -$3.2 million in Q4 2022 per RDHL's latest filing, from $987000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $17.8 million in Q2 2020 and bottomed at -$4.7 million in Q3 2020.
- Historically, Change in Accured Expenses has averaged $732400.0 across 5 years, with a median of $213000.0 in 2018.
- Annual changes were most pronounced in 2019 — Change in Accured Expenses plunged 3358.97% — and 2020, when it surged 6447.37%.
- RedHill Biopharma's Change in Accured Expenses stood at $117000.0 in 2018, then slumped by 3358.97% to -$3.8 million in 2019, then jumped by 149.78% to $1.9 million in 2020, then slumped by 83.72% to $309000.0 in 2021, then sank by 1151.78% to -$3.2 million in 2022.
- Business Quant data shows RDHL's Change in Accured Expenses at -$3.2 million in Q4 2022, $987000.0 in Q3 2022, and -$2.2 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -3.25 Mn |
| Dec 31, 2022 | -3.25 Mn |
| Sep 30, 2022 | 987,000.00 |
| Sep 30, 2022 | 987,000.00 |
| Jun 30, 2022 | -2.20 Mn |
| Jun 30, 2022 | -2.20 Mn |
| Mar 31, 2022 | 3.26 Mn |
| Mar 31, 2022 | 3.26 Mn |
| Dec 31, 2021 | 309,000.00 |
| Dec 31, 2021 | 309,000.00 |
| Sep 30, 2021 | -2.58 Mn |
| Sep 30, 2021 | -2.58 Mn |
| Jun 30, 2021 | -2.28 Mn |
| Jun 30, 2021 | -2.28 Mn |
| Mar 31, 2021 | 1.36 Mn |
| Mar 31, 2021 | 1.36 Mn |
| Dec 31, 2020 | 1.90 Mn |
| Dec 31, 2020 | 1.90 Mn |
| Sep 30, 2020 | -4.69 Mn |
| Sep 30, 2020 | -4.69 Mn |